Effectiveness of a new microbial sealant in reducing bacteremia, puncture site, and sheath contamination after percutaneous interventions: a single-center randomized study




Aim


To evaluate the effectiveness of the new film-forming cyanoacrylate liquid microbial sealant InteguSEAL⁎ (Kimberly-Clark) to reduce local skin bacteria contamination and bacteremia after percutaneous interventions (PI).




Methods


Sixty-three consecutive patients who underwent PI were randomized using a 1:1 allocation to receive either a standard skin preparation and application of InteguSEAL [31 patients (49.2%), Group A] or standard skin preparation [32 patients (51.8%), Group B]. All patients underwent puncture site skin flora cultures: immediately before and after skin preparation, prior to intervention conclusion (acute skin contamination), and 24–48 h postprocedure [late skin contamination (LSC)]. Blood cultures were taken upon procedure conclusion and prior to sheath removal in order to identify rates of acute bacteremia (AB). In patients with sheath removal >6 h, postprocedure blood cultures were taken prior to late sheath removal [late bacteremia (LB)], while the tip of the sheath was sent for microbial culture in order to identify late sheath contamination (LShC). All patients were followed up for 48 h and at 30 days postprocedure for the occurrence of clinical and laboratory signs of local or systemic infections.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Effectiveness of a new microbial sealant in reducing bacteremia, puncture site, and sheath contamination after percutaneous interventions: a single-center randomized study

Full access? Get Clinical Tree

Get Clinical Tree app for offline access